Showing results (441-450 of 479) with videos related to
Sort By:
Pageof 48
Neuroimage. Clinical|October 21, 2015
Default mode network segregation and social deficits in autism spectrum disorder: Evidence from non-medicated childrenBenjamin E Yerys, Evan M Gordon, Danielle N Abrams, et al.The British Journal of Psychiatry : the Journal of Mental Science|July 3, 2015
Heroin on trial: systematic review and meta-analysis of randomised trials of diamorphine-prescribing as treatment for refractory heroin addiction†John Strang, Teodora Groshkova, Ambros Uchtenhagen, et al.Lancet (London, England)|April 15, 2014
Use of contingency management incentives to improve completion of hepatitis B vaccination in people undergoing treatment for heroin dependence: a cluster randomised trialTim Weaver, Nicola Metrebian, Jennifer Hellier, et al.Addiction (Abingdon, England)|October 11, 2023
Cannabidiol does not attenuate acute delta-9-tetrahydrocannabinol-induced attentional bias in healthy volunteers: A randomised, double-blind, cross-over studyDominic Oliver, Amir Englund, Edward Chesney, et al.BMJ Open Quality|February 15, 2022
Golden opportunity for intervention? Identifying vitamin D deficiency in patients with substance use disorders in hospitalE Naomi Smith, Siobhan Gee, Gerri O'Brien, et al.Addiction (Abingdon, England)|April 24, 2019
Long-term safety of a weekly and monthly subcutaneous buprenorphine depot (CAM2038) in the treatment of adult out-patients with opioid use disorderMichael Frost, Genie L Bailey, Nicholas Lintzeris, et al.Trials|October 25, 2016
A randomised controlled trial of the clinical and cost-effectiveness of a contingency management intervention compared to treatment as usual for reduction of cannabis use and of relapse in early psychosis (CIRCLE): a study protocol for a randomised controlled trialSonia Johnson, Luke Sheridan Rains, Steven Marwaha, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 15, 2022
Does cannabidiol make cannabis safer? A randomised, double-blind, cross-over trial of cannabis with four different CBD:THC ratiosAmir Englund, Dominic Oliver, Edward Chesney, et al.Drug and Alcohol Dependence|June 16, 2022
A randomized clinical trial of the effects of brief versus extended opioid overdose education on naloxone utilization outcomes by individuals with opioid use disorderJermaine D Jones, Aimee N Campbell, Laura Brandt, et al.The American Journal on Addictions|March 19, 2021
Internet Addiction Increases in the General Population During COVID-19: Evidence From ChinaYang-Yang Li, Yan Sun, Shi-Qiu Meng, et al.Pageof 48